Peter A. Lichtenberg et al. - Handbook of Dementia: Psychological, Neurological, And Psychiatric Perspectives

Presents cutting-edge information on a variety of dementia-causing illnesses.
Provides relevant material for professionals working with AIDS patients, substance abusers, stroke or other vascular patients, and other individuals suffering from degenerative illness.
Edited by leading experts in geriatric health and dementia.

From the Back Cover
A comprehensive, multidisciplinary reference for diagnosing and treating dementia

The Handbook of Dementia offers a broad, interdisciplinary guide to understanding, diagnosing, and treating dementia and its related illnesses and conditions. In one volume, leading authorities provide insightful, specialized knowledge on the psychological, neurological, and psychiatric aspects of dementia, including etiology and diagnosis, assessment tools, behavioral and pharmacological treatments, and comorbidities. This practical guide also addresses multicultural issues as they relate to the diagnosis and treatment process.

Edited by renowned experts in geriatric health and dementia, Handbook of Dementia presents cutting-edge information on a variety of dementia-causing illnesses, such as AIDS, substance abuse, stroke and other vascular diseases, degenerative diseases of the nervous system (including Alzheimer’s), and many others. Aimed at improving the quality of life for those suffering from dementia, this hands-on guide’s unique features include interventions focused on cognitive and noncognitive functions, a psychological model that "rules in" influences on behavior, and revealing information specific to particular types of dementia.

The most comprehensive reference on dementia in the field, the Handbook of Dementia is the state-of-the-art resource for effectively working with clients who suffer from this and related conditions.

Reviews

“

“…what an excellent book this is…buy this one…” (International Journal of Geriatric Psychiatry, Vol. 20 (4), April 2005) "...gives you a broad interdisciplinary approach…recommend to professionals working with this disability population..." (International Journal of Adolescent Med and Health, Vol 16(1), 2004)

”

Reviews on Amazon:

“

Peter A Lichtenberg is the director of the Institute of Gerontology and professor of Psychology at Wayne State University in Detroit, Michigan, Daniel L Murman is the director of Geriatric, Neurology and Memory Disorder Clinic and assistant professor in the departments of neurology and ophthalmology at Michigan State University, East Lansing, while Alan M Mellow is the chief of the Division of Geriatric Psychiatry and associate professor of psychiatry at the University of Michigan in Ann Arbor. One of the first cases of dementia was described by professor Alois Alzheimer, Germany, in 1906. He first examined Auguste D, a 51-year old female patient, at Frankfurt hospital in 1901 and continued to follow her case after he left for the Royal Psychiatric Clinic in Munich, up until her death on April 8th, 1906. Even after her death he went on to study the neuropathological features of her illness. Shortly after her death he presented her case at the 37th Conference of German Psychiatrist in Tubingen on Nevember 4th, 1906 in which he described her symptoms as progressive cognitive impairment, focal symptoms, hallucinations, delusions, psychosocial incompetence with the following neurobiological changes found at autopsy: plaques, neurofibrillary tangles and artheriosclerotic changes. Alzheimer's disease (AD) effects about 2-3% of persons at age 65 years with a doubling of incidence for every five years of age afterwards. AD is the most common cause of dementia in western countries. Approximately 10 percent of all persons over 70 years have significant memory loss and more than half is the result of AD, which translates to about 3-4 million persons in the United States. This results in a total health care cost of more than 50 billion dollars per year in the United States and the estimated annual cost of caring for a single AD patient in an advanced stage of the disease is USDollars 47,000. Clinicaly AD most often presents with a subtle onset of memory loss followed by a slowly progressive dementia that has a course of several years. Adults with trisomy 21 (Down syndrome, DS) develop the typical neuropathological hallmarks of AD if they survive beyond 40 years. Many also develop a progressive dementia superimposed on the baseline intellectual disability. This handbook with 22 contributors gives you a broad interdiscplinary approach to the diagnosis, treatment and comorbidities of dementia, which we would like to recommend to professionals working with this disability population. Professor Joav Merrick, MD Director, National Institute of Child Health and Human Development and Medical director, Division for Mental Retardation, Box 1260, IL-91012 Jerusalem, Israel

”